A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis

PHASE2TerminatedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 12, 2019

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Interdigital Tinea Pedis
Interventions
DRUG

Cohort 1 J. Lividum

Subject to apply DBI-001 Gel on each foot covering all web spaces, the plantar and lateral aspects, toes and toenails

OTHER

Placebo Gel

Subject to apply Placebo Gel daily on each foot covering all web spaces, the plantar and lateral aspects, toes and toenails.

Trial Locations (1)

Unknown

Instituto Dermatologico y Cirugia de Piel, Santo Domingo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DermBiont, Inc.

INDUSTRY

NCT04315051 - A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis | Biotech Hunter | Biotech Hunter